Net Income Summary of SCI Pharmtech, Inc.

SCI Pharmtech, Inc.'s latest annual net income in 2023 was 294.72 Million TWD , down -4.55% from previous year.
SCI Pharmtech, Inc.'s latest quarterly net income in 2024 Q2 was 62.19 Million TWD , up 39.73% from previous quarter.
SCI Pharmtech, Inc. reported an annual net income of 308.78 Million TWD in 2022, up 454.4% from previous year.
SCI Pharmtech, Inc. reported an annual net income of 55.69 Million TWD in 2021, down -84.53% from previous year.
SCI Pharmtech, Inc. reported a quarterly net income of 44.5 Million TWD for 2024 Q1, up 1332.59% from previous quarter.
SCI Pharmtech, Inc. reported a quarterly net income of 35.37 Million TWD for 2023 Q3, down -82.27% from previous quarter.

Annual Net Income Chart of SCI Pharmtech, Inc. (2023 - 2009)

Historical Annual Net Income of SCI Pharmtech, Inc. (2023 - 2009)

Year	Net Income	Net Income Growth
2023	294.72 Million TWD	-4.55%
2022	308.78 Million TWD	454.4%
2021	55.69 Million TWD	-84.53%
2020	360.12 Million TWD	-36.94%
2019	571.1 Million TWD	27.7%
2018	447.23 Million TWD	134.18%
2017	190.97 Million TWD	-54.2%
2016	416.95 Million TWD	11.51%
2015	373.9 Million TWD	41.18%
2014	264.83 Million TWD	65.59%
2013	159.93 Million TWD	-17.75%
2012	194.44 Million TWD	116.02%
2011	90.01 Million TWD	-47.43%
2010	171.24 Million TWD	2.97%
2009	166.31 Million TWD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	62.19 Million TWD	39.73%
2024 Q1	44.5 Million TWD	1332.59%
2023 Q3	35.37 Million TWD	-82.27%
2023 Q4	-3.61 Million TWD	-110.21%
2023 Q1	63.43 Million TWD	-19.34%
2023 Q2	199.51 Million TWD	214.51%
2023 FY	294.72 Million TWD	-4.55%
2022 Q2	140.34 Million TWD	240.86%
2022 FY	308.78 Million TWD	454.4%
2022 Q1	41.17 Million TWD	309.55%
2022 Q4	78.64 Million TWD	61.78%
2022 Q3	48.61 Million TWD	-65.36%
2021 Q1	41.67 Million TWD	114.95%
2021 Q3	29.92 Million TWD	697.65%
2021 Q2	3.75 Million TWD	-91.0%
2021 FY	55.69 Million TWD	-84.53%
2021 Q4	-19.64 Million TWD	-165.67%
2020 FY	360.12 Million TWD	-36.94%
2020 Q2	241.67 Million TWD	16.0%
2020 Q3	188.91 Million TWD	-21.83%
2020 Q4	-278.79 Million TWD	-247.58%
2020 Q1	208.33 Million TWD	132.78%
2019 Q1	164.04 Million TWD	48.77%
2019 Q4	89.49 Million TWD	-44.0%
2019 FY	571.1 Million TWD	27.7%
2019 Q3	159.82 Million TWD	1.33%
2019 Q2	157.72 Million TWD	-3.85%
2018 Q3	126.88 Million TWD	-14.92%
2018 FY	447.23 Million TWD	134.18%
2018 Q4	110.26 Million TWD	-13.1%
2018 Q2	149.13 Million TWD	144.68%
2018 Q1	60.95 Million TWD	2.96%
2017 Q4	59.19 Million TWD	45.62%
2017 FY	190.97 Million TWD	-54.2%
2017 Q1	51.4 Million TWD	50.69%
2017 Q2	39.72 Million TWD	-22.72%
2017 Q3	40.65 Million TWD	2.34%
2016 Q1	156.93 Million TWD	156.71%
2016 Q3	94.42 Million TWD	-28.18%
2016 Q4	34.11 Million TWD	-63.88%
2016 FY	416.95 Million TWD	11.51%
2016 Q2	131.47 Million TWD	-16.22%
2015 Q1	92.81 Million TWD	95.92%
2015 Q2	124.75 Million TWD	34.4%
2015 FY	373.9 Million TWD	41.18%
2015 Q3	95.2 Million TWD	-23.69%
2015 Q4	61.13 Million TWD	-35.79%
2014 Q2	93.18 Million TWD	46.5%
2014 Q4	47.37 Million TWD	-21.92%
2014 FY	264.83 Million TWD	65.59%
2014 Q1	63.6 Million TWD	72.18%
2014 Q3	60.67 Million TWD	-34.88%
2013 FY	159.93 Million TWD	-17.75%
2013 Q3	22.77 Million TWD	-51.14%
2013 Q4	36.94 Million TWD	62.18%
2013 Q2	46.61 Million TWD	-13.02%
2013 Q1	53.6 Million TWD	-3.75%
2012 Q2	35.25 Million TWD	-38.25%
2012 Q1	57.09 Million TWD	281.27%
2012 Q4	55.69 Million TWD	18.75%
2012 Q3	46.89 Million TWD	33.02%
2012 FY	194.44 Million TWD	116.02%
2011 Q3	38.29 Million TWD	7.66%
2011 Q1	47.65 Million TWD	8.81%
2011 Q2	35.56 Million TWD	-25.36%
2011 FY	90.01 Million TWD	-47.43%
2011 Q4	-31.49 Million TWD	-182.25%
2010 FY	171.24 Million TWD	2.97%
2010 Q2	48.67 Million TWD	17.89%
2010 Q1	41.28 Million TWD	0.0%
2010 Q4	43.79 Million TWD	16.83%
2010 Q3	37.48 Million TWD	-22.99%
2009 FY	166.31 Million TWD	0.0%

Peer Net Income Comparison of SCI Pharmtech, Inc.

Name	Net Income	Net Income Difference
Grape King Bio Ltd	1.45 Billion TWD	79.713%
Standard Chem & Pharm CO., LTD.	834.88 Million TWD	64.699%
Maywufa Company Ltd.	169.09 Million TWD	-74.29%
ScinoPharm Taiwan, Ltd.	287.05 Million TWD	-2.67%
Lotus Pharmaceutical Co., Ltd.	4.1 Billion TWD	92.822%
LIWANLI Innovation Co., Ltd.	5.1 Million TWD	-5675.446%
YungShin Global Holding Corporation	827.3 Million TWD	64.376%
PhytoHealth Corporation	-47.11 Million TWD	725.509%
Formosa Laboratories, Inc.	126.24 Million TWD	-133.455%
PharmaEssentia Corporation	-623.83 Million TWD	147.243%
Bora Pharmaceuticals Co., LTD.	3.03 Billion TWD	90.274%

Global Stocks Search

SCI Pharmtech, Inc. (4119.TW)

Net Income Summary of SCI Pharmtech, Inc.

Annual Net Income Chart of SCI Pharmtech, Inc. (2023 - 2009)

Historical Annual Net Income of SCI Pharmtech, Inc. (2023 - 2009)

Peer Net Income Comparison of SCI Pharmtech, Inc.